| Title | Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy (ADVANCE) |
|---|---|
| Disease/Condition | Skin Disorders,Dermatology,Psoriasis |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Holly Kanavy, MD |
| Contact Name | Jose Jaller |
| Contact Email | jjaller@montefiore.org |
| Protocol Number | 18-02-294-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Dermatology - Plaque Psoriasis |
| Adult, Pediatric, Both | Adult |